Skip to main content

Inside the Market Thursday’s Insider Report: CEO takes advantage of price weakness and invests over $700,000

Featured below are companies that have experienced recent insider trading activity in the public market through their direct and indirect ownerships, including accounts they have control or direction over.

The list features insider transaction activity; it does not convey total ownership information as an insider may hold numerous accounts.

Keep in mind, when looking at transaction activities by insiders, purchasing activity may reflect perceived value in a security. Selling activity may or may not be related to a stock’s valuation; perhaps an insider needs to raise money for personal reasons. An insider’s total holdings should be considered because a sale may, in context, be insignificant if this person has a large remaining position in the company. I tend to put great weight on insider transaction activity when I see multiple insiders trading a company’s shares or units.

Story continues below advertisement

Listed below are two securities that have had recent insider buying activity.

Cominar Real Estate Investment Trust (CUF.UN-T)

On March 27, Paul Campbell, who sits on the board of trustees, bought 18,000 units at a price per unit of $11.85, raising his account balance to 21,600 units. The cost of this purchase totaled over $213,000.

Knight Therapeutics Inc. (GUD-T)

On March 22, founder, chief executive officer and director Jonathan Goodman acquired 99,000 shares at an average price per share of $7.525, increasing the portfolio’s holdings to 435,520 shares. The cost of this purchase exceeded $745,000.

Previously, we reported that the company’s president and chief financial officer Samira Sakhia invested approximately $100,000 in shares of Knight Therapeutics on March 19. Ms. Sakhia bought 12,987 shares at a price per share of $7.70, lifting her account’s holdings to 35,174 shares.

**

Story continues below advertisement

Listed below is a stock that has had recent selling activity reported by an insider.

First Majestic Silver Corp. (FR-T)

Between March 22 and March 27, director Robert McCallum exercised his options, receiving 22,816 shares, and sold 20,000 shares at a price per share of $9.35 with a closing account balance of 32,816 shares. Proceeds from the sale totaled $187,000.

**

Listed below is a stock that has had both recent buying and selling activity reported by insiders.

NFI Group Inc. (NFI-T)

Story continues below advertisement

Between March 18 and March 26, James Sardo, who sits on the board of directors, exercised his rights, receiving 1,044 shares, and sold 2,500 shares at an average price per share of approximately $31.99 with 14,638 shares remaining in the account. Proceeds from the sales totaled roughly $80,000.

On March 18, Alexander Kirshner, vice-president of information technology, acquired 6,600 shares at a price per share of $30.20, which took the account’s holdings up to 6,758 shares. The cost of this investment was roughly $200,000.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter